Hong Kong stock market anomaly | BeiBo Pharmaceutical-B (02142.HK) fell more than 10% during trading hours. Pfizer announced the termination of all research and development of BeiBo ADC drug SGN-MesoC2.

According to the Wise Finance and Economics app, the share price of Hutchison Pharmacy-B (02142.HK) fell more than 10% during trading hours. As of the time of writing, it has fallen by 6.86% to 11.68 Hong Kong dollars, with a trading volume of 44.7275 million Hong Kong dollars.